Clinical Trials
42 trialsEstablishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
Peking University First Hospital
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
ONFM-SBRT
Peking University Third Hospital
Renal Autotransplantation; Case Series
Methodist Health System
Patient Reported Outcome After Nephron Sparing Treatment of Small Renal Tumours
Region of Southern Denmark
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes
RenJi Hospital
ANGIOCOR
Assistance Publique - Hôpitaux de Paris
Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
Zhejiang Cancer Hospital
IMCOR
Institut de cancérologie Strasbourg Europe
Biomarkers of Response to Systemic Treatments in FH-deficient RCC
RenJi Hospital
CICERONE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
PDXovo
Sunnybrook Health Sciences Centre
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
TScan Therapeutics, Inc.
I-Rene
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma
Humanitas Clinical and Research Center
Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors
M.D. Anderson Cancer Center
PIONEER
SpeciCare
ENRC
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
PANMEKID
Universidad de Extremadura
Observational Study of Camrelizumab Combined With Apatinib and Hyperfractionated Radiotherapy for Renal Cell Carcinoma
Peking University First Hospital
Residual Normal Renal Parenchymal and Tumor Volume in Tumor Surgeries
Assiut University
TRACERxRenal
Royal Marsden NHS Foundation Trust
BIII
Maastricht University
ICI-DISCOVER
Università Politecnica delle Marche
LMR
Corporacion Parc Tauli
Development and Evaluation of High Risk Group Prediction Model in T1 Stage Renal Cell Cancer Using Molecular Biomarkers
Yonsei University
ARTIST_RCC
Cambridge University Hospitals NHS Foundation Trust
MERLIN
Centre Hospitalier Universitaire de Besancon
NISar
Odense University Hospital
Preventive Effects of Aspirin as Adjuvant Therapy in Patients With Locally Advanced Renal Cell Carcinoma
RenJi Hospital
TOPTACOS
Institut Cancerologie de l'Ouest
Foresight
Maastricht University Medical Center
ExhauCRF
European Georges Pompidou Hospital
VE-CART
Centre Hospitalier Universitaire, Amiens
Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?
University of Copenhagen
Metabolomic Profiling in Renal Cell Carcinoma
Cambridge University Hospitals NHS Foundation Trust
Prognostic Significance of Preoperative Hemoglobin A1c (HbA1c) in Renal Cell Carcinoma
Seoul National University Hospital
Value of Various Chemokines in the Detection and Follow up of RCC
Carmel Medical Center
CRESTO
Western Sydney Local Health District
Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
National Cancer Institute (NCI)
LapVsOpen prtn
Rabin Medical Center